1. Anjum A, Yazid MD, Fauzi Daud M, Idris J, Ng AMH, Selvi Naicker A, Ismail OHR, Athi Kumar RK, Lokanathan Y (2020) Spinal cord injury: pathophysiology, multimolecular interactions, and underlying recovery mechanisms. Int J Mol Sci 21:7533
2. Bahceci I, Tumkaya L, Mercantepe T, Aslan N, Duran OF, Soztanaci US (2022) Yazici ZA (2022) Inhibition of methotrexate induced toxicity in the adult rat spleen by adalimumab. Drug Chem Toxicol 10(1080/01480545):2029880
3. Basso DM, Beattie MS, Bresnahan JC (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12:1–21
4. Bhoopalan SV, Huang LJ, Weiss MJ (2020) Erythropoietin regulation of red blood cell production: from bench to bedside and back. F100Res 9:1153
5. Celik H, Karatay M, Erdem Y, Yildirim AE, Sertbas I, Karatay E, Kul H, Guvenc Y, Koksal I, Menekse G, Alagoz F, Kertmen HH, Caydere M (2016) The biochemical, histopathological and clinical comparison of the neuroprotective effects of subcutaneous adalimumab and intravenous methylprednisolone in an experimental compressive spinal cord trauma model. Turk Neurosurg 26:622–631